Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Meijer

Showing results (331-340 of 378) with videos related to

Pageof 38
Sort By:
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 7, 2018
The Amsterdam ReBus progressor cohort: identification of 165 Barrett's surveillance patients who progressed to early neoplasia and 723 nonprogressor patientsL C Duits, E Klaver, A Bureo Gonzalez, et al.
JAMA|March 27, 2014
Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trialK Nadine Phoa, Frederike G I van Vilsteren, Bas L A M Weusten, et al.
Journal of Translational Medicine|April 18, 2015
Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tractHelene Damhofer, Eva A Ebbing, Anne Steins, et al.
Journal of Medical Imaging (Bellingham, Wash.)|March 1, 2018
<i>Ex-vivo</i> study in nephroureterectomy specimens defining the role of 3-D upper urinary tract visualization using optical coherence tomography and endoluminal ultrasoundMieke T J Bus, Paul Cernohorsky, Daniel M de Bruin, et al.
Cancers|June 19, 2019
Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study)Sandor Schokker, Stephanie O van der Woude, Jessy Joy van Kleef, et al.
Endoscopy|February 20, 2024
Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett's neoplasia: a nationwide cohort with pathology reassessmentLaurelle van Tilburg, Eva P D Verheij, Steffi E M van de Ven, et al.
Frontiers in Pharmacology|November 3, 2023
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational studyLenka N C Boyd, Lynn E Nooijen, Mahsoem Ali, et al.
Gastroenterology|December 26, 2016
Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to NeoplasiaLucas C Duits, Myrtle J van der Wel, Cary C Cotton, et al.
Heliyon|July 6, 2023
Clinical characteristics and long-term outcomes following pancreatic injury - An international multicenter cohort studyLaura L Meijer, Yrjö Vaalavuo, Sara Regnér, et al.
United European Gastroenterology Journal|August 21, 2019
Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagusM J van der Wel, E Klaver, L C Duits, et al.
Pageof 38

Showing results (331-340 of 378) with videos related to

Sort By:
Pageof 38
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 7, 2018
The Amsterdam ReBus progressor cohort: identification of 165 Barrett's surveillance patients who progressed to early neoplasia and 723 nonprogressor patientsL C Duits, E Klaver, A Bureo Gonzalez, et al.
JAMA|March 27, 2014
Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trialK Nadine Phoa, Frederike G I van Vilsteren, Bas L A M Weusten, et al.
Journal of Translational Medicine|April 18, 2015
Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tractHelene Damhofer, Eva A Ebbing, Anne Steins, et al.
Journal of Medical Imaging (Bellingham, Wash.)|March 1, 2018
<i>Ex-vivo</i> study in nephroureterectomy specimens defining the role of 3-D upper urinary tract visualization using optical coherence tomography and endoluminal ultrasoundMieke T J Bus, Paul Cernohorsky, Daniel M de Bruin, et al.
Cancers|June 19, 2019
Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study)Sandor Schokker, Stephanie O van der Woude, Jessy Joy van Kleef, et al.
Endoscopy|February 20, 2024
Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett's neoplasia: a nationwide cohort with pathology reassessmentLaurelle van Tilburg, Eva P D Verheij, Steffi E M van de Ven, et al.
Frontiers in Pharmacology|November 3, 2023
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational studyLenka N C Boyd, Lynn E Nooijen, Mahsoem Ali, et al.
Gastroenterology|December 26, 2016
Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to NeoplasiaLucas C Duits, Myrtle J van der Wel, Cary C Cotton, et al.
Heliyon|July 6, 2023
Clinical characteristics and long-term outcomes following pancreatic injury - An international multicenter cohort studyLaura L Meijer, Yrjö Vaalavuo, Sara Regnér, et al.
United European Gastroenterology Journal|August 21, 2019
Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagusM J van der Wel, E Klaver, L C Duits, et al.
Pageof 38